$ENRT
Enertopia Corp. Stock $enrt

$enrt Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000106299320003293 Filed on July 14, 2020

Income Statement

Concept	2020 Q2	2019 Q3	2019 Q2
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$31.55K	$51.44K	$60.91K
YoY Change	-48.2%	-35.7%	-59.39%
% of Gross Profit
Research & Development	$266.00	$1.030K	$6.163K
YoY Change	-95.68%		-69.19%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$33.18K	$52.46K	$68.39K
YoY Change	-51.49%	-34.43%	-59.77%
Operating Profit	-$33.18K		-$68.39K
YoY Change	-51.49%
Interest Expense	$321.00	-$3.490K	$307.00
YoY Change	4.56%
% of Operating Profit
Other Income/Expense, Net	$1.959K		$7.543K
YoY Change	-74.03%		-175.43%
Pretax Income	-$30.80K	-$55.96K	-$67.13K
YoY Change	-54.12%	-30.05%	-62.71%
Income Tax
% Of Pretax Income
Net Earnings	-$30.80K	-$55.96K	-$67.13K
YoY Change	-54.12%	-30.05%	-62.71%
Net Earnings / Revenue
Basic Earnings Per Share	$0.00
Diluted Earnings Per Share	$0.00	-$438.90	-$544.60
COMMON SHARES
Basic Shares Outstanding	128.5M shares
Diluted Shares Outstanding	128.5M shares

Balance Sheet

Concept	2020 Q2	2019 Q3	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$92.78K	$9.760K	$14.20K
YoY Change	553.38%	-94.58%	-89.08%
Cash & Equivalents	$92.78K	$9.758K	$14.20K
Short-Term Investments
Other Short-Term Assets	$10.94K	$30.26K	$44.79K
YoY Change	-75.57%	-66.38%	-62.68%
Inventory
Prepaid Expenses	$10.94K	$30.26K
Receivables	$855.00	$6.225K	$4.830K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$104.6K	$46.25K	$63.82K
YoY Change	63.86%	-82.87%	-74.47%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$104.6K	$46.25K	$63.82K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$104.6K	$46.25K	$63.82K
YoY Change	63.86%	-82.87%	-74.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$271.8K	$283.4K	$277.3K
YoY Change	-1.99%	1.23%	2.7%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$15.48K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$466.3K	$502.1K	$463.7K
YoY Change	0.55%	11.58%	0.81%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$466.3K	$502.1K	$463.7K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$466.3K	$502.1K	$463.7K
YoY Change	0.55%	11.58%	0.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$14.25M	-$14.31M
YoY Change
Common Stock		$127.5K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$361.7K	-$455.9K	-$399.9K
YoY Change
Total Liabilities & Shareholders Equity	$104.6K	$46.25K	$63.82K
YoY Change	63.86%	-82.87%	-74.47%

Cashflow Statement

Concept	2020 Q2	2019 Q3	2019 Q2
OPERATING ACTIVITIES
Net Income	-$30.80K	-$55.96K	-$67.13K
YoY Change	-54.12%	-30.05%	-62.71%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$39.30K	-$19.75K	-$94.33K
YoY Change	-58.34%	-60.5%	-5.67%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	15.30K	97.06K
YoY Change	-100.0%	-84.7%	-51.47%
NET CHANGE
Cash From Operating Activities	-39.30K	-19.75K	-94.33K
Cash From Investing Activities	0.000
Cash From Financing Activities	0.000	15.30K	97.06K
Net Change In Cash	-39.30K	-4.450K	2.730K
YoY Change	-1539.56%	-108.9%	-97.27%
FREE CASH FLOW
Cash From Operating Activities	-$39.30K	-$19.75K	-$94.33K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	176409	USD
CY2019Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14202	USD
CY2020Q2	us-gaap	Liabilities Current LiabilitiesCurrent	466284	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-494003	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-330910	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	145785	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-30797	USD
	us-gaap	Net Income Loss NetIncomeLoss	65381	USD
	us-gaap	Net Income Loss NetIncomeLoss	-366383	USD
CY2020Q1	enrt	Stock Options Granted February Two Five StockOptionsGrantedFebruaryTwoFive	17308	USD
CY2020Q2	us-gaap	Professional Fees ProfessionalFees	8006	USD
CY2019Q2	us-gaap	Professional Fees ProfessionalFees	13896	USD
	us-gaap	Professional Fees ProfessionalFees	29831	USD
	us-gaap	Professional Fees ProfessionalFees	40019	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	321	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	307	USD
	us-gaap	Interest Expense InterestExpense	1383	USD
	us-gaap	Interest Expense InterestExpense	788	USD
CY2020Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	13322	USD
CY2019Q2	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	10500	USD
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	23822	USD
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	33450	USD
CY2020Q2	enrt	Mineral Exploration Costs MineralExplorationCosts	1046	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-204456	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-67128	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-55958	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-49607	USD
CY2019Q2	enrt	Shares Issued For Private Placement On March Two Seven SharesIssuedForPrivatePlacementOnMarchTwoSeven	97061	USD
CY2019Q4	enrt	Stock Issued During Period Value For Letter Of Intent On October Two Eight StockIssuedDuringPeriodValueForLetterOfIntentOnOctoberTwoEight	11489	USD
CY2020Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10939	USD
CY2019Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	30262	USD
CY2019Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127471700	shares
CY2020Q2	us-gaap	Assets Current AssetsCurrent	104577	USD
	us-gaap	Share Based Compensation ShareBasedCompensation		USD
CY2020Q2	us-gaap	Assets Assets	104577	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	-225404	USD
CY2019Q3	us-gaap	Assets Assets	46245	USD
CY2020Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	271769	USD
CY2019Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	283430	USD
CY2019Q3	us-gaap	Loans Payable Current LoansPayableCurrent	15479	USD
CY2020Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	194515	USD
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	203221	USD
CY2019Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6225	USD
	dei	Document Period End Date DocumentPeriodEndDate	2020-05-31
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9758	USD
CY2019Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127471700	shares
CY2020Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	855	USD
CY2019Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	128471700	shares
CY2019Q3	us-gaap	Liabilities Current LiabilitiesCurrent	502130	USD
CY2019Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2019Q3	us-gaap	Common Stock Value CommonStockValue	127473	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	-429860	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	-455885	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	-177580	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	-399927	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	-94799	USD
CY2019Q3	us-gaap	Assets Current AssetsCurrent	46245	USD
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	128471700	shares
CY2020Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13758598	USD
CY2019Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13730801	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14248778	USD
CY2019Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-14314159	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-361707	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	104577	USD
CY2019Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	46245	USD
CY2018Q4	enrt	Shares Issued For Private Placement On September Two One SharesIssuedForPrivatePlacementOnSeptemberTwoOne	46975	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	2000000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.02
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.02
	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-361707	USD
CY2019	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-455885	USD
CY2019Q2	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	20460	USD
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	18166	USD
	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	90842	USD
CY2020Q2	us-gaap	Legal Fees LegalFees	780	USD
CY2019Q2	us-gaap	Legal Fees LegalFees	1628	USD
	us-gaap	Legal Fees LegalFees	8190	USD
	us-gaap	Legal Fees LegalFees	6298	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	802	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	666	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	938	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4689	USD
CY2020Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	266	USD
CY2019Q2	enrt	Mineral Exploration Costs MineralExplorationCosts	1007	USD
	enrt	Mineral Exploration Costs MineralExplorationCosts	14671	USD
	enrt	Mineral Exploration Costs MineralExplorationCosts	125539	USD
CY2020Q2	us-gaap	Other Expenses OtherExpenses	1959	USD
CY2019Q2	us-gaap	Other Expenses OtherExpenses	7543	USD
	us-gaap	Other Expenses OtherExpenses	17698	USD
	us-gaap	Other Expenses OtherExpenses	29018	USD
CY2019Q2	us-gaap	General Insurance Expense GeneralInsuranceExpense	2994	USD
	us-gaap	General Insurance Expense GeneralInsuranceExpense	3605	USD
	us-gaap	General Insurance Expense GeneralInsuranceExpense	9036	USD
CY2020Q2	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	6677	USD
CY2019Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6163	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	760	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10586	USD
CY2019Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1462	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1963	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5158	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	17308	USD
CY2019Q2	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	1764	USD
	us-gaap	Travel And Entertainment Expense TravelAndEntertainmentExpense	10670	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	33179	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	68390	USD
	us-gaap	Operating Expenses OperatingExpenses	138335	USD
	us-gaap	Operating Expenses OperatingExpenses	366093	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-33179	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-68390	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-138335	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-366093	USD
CY2020Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2382	USD
CY2019Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1262	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3716	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-290	USD
	us-gaap	Royalty Income Nonoperating RoyaltyIncomeNonoperating	200000	USD
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2019Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	9748	USD
CY2019Q1	enrt	Units Issued During Period Value UnitsIssuedDuringPeriodValue	106809	USD
CY2018Q3	enrt	Class Of Warrant Or Right Grants In Period Contractual Term ClassOfWarrantOrRightGrantsInPeriodContractualTerm	P36M
CY2019Q1	enrt	Class Of Warrant Or Right Grants In Period Contractual Term ClassOfWarrantOrRightGrantsInPeriodContractualTerm	P48M
CY2018Q3	enrt	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	0.05
CY2019Q1	enrt	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	0.04
CY2018Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	6075	CAD
CY2019Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	13068	CAD
CY2018Q3	enrt	Units Issued During Period UnitsIssuedDuringPeriod	2225000	shares
CY2019Q1	enrt	Units Issued During Period UnitsIssuedDuringPeriod	5506769	shares
CY2018Q3	enrt	Units Issued During Period Per Unit Amount UnitsIssuedDuringPeriodPerUnitAmount	0.03
CY2019Q1	enrt	Units Issued During Period Per Unit Amount UnitsIssuedDuringPeriodPerUnitAmount	0.03
CY2018Q3	enrt	Units Issued During Period Value UnitsIssuedDuringPeriodValue	66750	CAD
CY2018Q3	enrt	Units Issued During Period Value UnitsIssuedDuringPeriodValue	51678	USD
CY2019Q1	enrt	Units Issued During Period Value UnitsIssuedDuringPeriodValue	143176	CAD
CY2018Q3	enrt	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	202500	shares
CY2019Q1	enrt	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	502600	shares
CY2019	enrt	Class Of Warrant Or Right Grants In Period ClassOfWarrantOrRightGrantsInPeriod	8436869	shares
CY2019	enrt	Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePrice	0.04
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8320000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8570000	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.07
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.07
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.05
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	250000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1000000	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.05
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y8M19D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y4M17D
CY2018Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	40739060	shares
CY2019Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	26141459	shares
CY2020Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	13236869	shares
CY2018Q3	enrt	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	0.06
	enrt	Class Of Warrant Or Right Expirations In Period Weighted Average Exercise Price ClassOfWarrantOrRightExpirationsInPeriodWeightedAverageExercisePrice	0.06
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.01
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.63	pure
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0116	pure
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9320000	shares
CY2019Q3	enrt	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	0.06
CY2020Q2	enrt	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	0.05
CY2019	enrt	Class Of Warrant Or Right Expirations In Period ClassOfWarrantOrRightExpirationsInPeriod	23034470	shares
	enrt	Class Of Warrant Or Right Expirations In Period ClassOfWarrantOrRightExpirationsInPeriod	12904590	shares
CY2019	enrt	Class Of Warrant Or Right Expirations In Period Weighted Average Exercise Price ClassOfWarrantOrRightExpirationsInPeriodWeightedAverageExercisePrice	0.07
CY2019Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.00
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
CY2020Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	128471700	shares
CY2019Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	123276066	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	128260021	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	123104913	shares
	us-gaap	Employee Benefits And Share Based Compensation Noncash EmployeeBenefitsAndShareBasedCompensationNoncash	17308	USD
	enrt	Shares Issued For Exploration Cost SharesIssuedForExplorationCost	11489	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	699	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5370	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2677	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-19323	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-42989	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-11871	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-756	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-8706	USD
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	15230	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-101007	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-306243	USD
	enrt	Proceeds From Sale Of Royalty Grant ProceedsFromSaleOfRoyaltyGrant	200000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	200000	USD
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	15968	USD
	enrt	Net Proceeds From Subscriptions Received NetProceedsFromSubscriptionsReceived	144036	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-15968	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	144036	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	83025	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-162207	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	us-gaap	Interest Paid Net InterestPaidNet	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div><div><div><p style="margin-left:99pt;text-indent:-84pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif"><strong>b)</strong><span style="width:13.11pt;text-indent:0pt;display:inline-block"> </span><strong>Accounting Estimates</strong></span></span></p><p style="margin-left:36pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.  On an ongoing basis, we evaluate our estimates, judgments, and assumptions, including those related to revenue recognition, inventory valuation, and stock based compensation (expense and liability). Our estimates, judgments, and assumptions are based on historical experience, future expectations, and other factors which we believe to be reasonable. Actual results could differ from those estimates and assumptions.</span></span></p></div></div></div>
	enrt	Percentage Of Land Rights Interest PercentageOfLandRightsInterest	1	pure
CY2020Q1	enrt	Percentage Of Royalty Agreement PercentageOfRoyaltyAgreement	0.01	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	2000000	shares
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P2Y
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.10
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	Segment

Files In Submission

Name	View Source	Status
0001062993-20-003293-index-headers.html	Edgar Link	pending
0001062993-20-003293-index.html	Edgar Link	pending
0001062993-20-003293.txt	Edgar Link	pending
0001062993-20-003293-xbrl.zip	Edgar Link	pending
enrt-20200531.xml	Edgar Link	completed
enrt-20200531.xsd	Edgar Link	pending
enrt-20200531_cal.xml	Edgar Link	unprocessable
enrt-20200531_def.xml	Edgar Link	unprocessable
enrt-20200531_lab.xml	Edgar Link	unprocessable
enrt-20200531_pre.xml	Edgar Link	unprocessable
exhibit31-1.htm	Edgar Link	pending
exhibit31-2.htm	Edgar Link	pending
exhibit32-1.htm	Edgar Link	pending
exhibit32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
form10q.htm	Edgar Link	pending
form10qx001.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ENRT
Enertopia Corp. Stock $enrt

2020 Q2 Form 10-Q Financial Statement

#000106299320003293 Filed on July 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENRT Enertopia Corp. Stock $enrt

2020 Q2 Form 10-Q Financial Statement

#000106299320003293 Filed on July 14, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENRT
Enertopia Corp. Stock $enrt